BioSense
PrivateLast Round
Grant
Sep 30, 2020
Company Overview
BioSense operates in Healthcare & Life Sciences and is based in Beverly Hills, Michigan. Its latest recorded funding round was a Grant round in September 2020.
BioSense is a medical technology company that develops non-contact ECG monitoring solutions for constant, non-invasive patient monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSense Comparables
Compare BioSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Electrocept | 94% | |
| Capical GmbH | 81% | |
| SensVita, Inc. | 81% |
For institutional investors. Book with your work email.
BioSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2020 | ||||
| Accelerator | Jun 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Alliance for Pediatric Device Innovation | Grant |
| Food and Drug Administration | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 76% MoM.
- Sep 30, 2020
Received grant from Alliance for Pediatric Device Innovation and FDA.
For institutional investors. Book with your work email.
BioSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioSense's valuation, stock price, and market status.
Is BioSense a public or private company?
BioSense is a private company.
What is the current stock price of BioSense?
BioSense is a private company, so its shares have no public market price. Caplight tracks BioSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioSense worth (valuation)?
Valuation information for BioSense is not publicly available.
Can I buy BioSense stock?
BioSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioSense's last funding round?
BioSense's most recent funding round was Grant on September 30, 2020.
Who are the main investors in BioSense?
Key investors in BioSense include MedTech Innovator, Alliance for Pediatric Device Innovation, Food and Drug Administration.
Will BioSense IPO soon?
No public IPO plans have been announced for BioSense.
How can I track BioSense secondary market activity?
Caplight tracks bids, offers, and trades in BioSense's shares on secondary markets.